Fohn (1904) , stated that the Jaffe reaction was given by acetone, acetoacetic acid and its ester which, if present, could be easily removed. Greenwald ( 19 13) also reported interference due to acetone and acetoacetic acid in the estimation of creatinine in the urines obtained from diabetic patients.
There have been conflicting reports about the interference of acetoacetate on the Jaffe reaction. Positive errors have been reported by Watkins (1067), Fabiny & Ertingshausen (1971) , Larsen (1972) , Kammeraat (1978) and Lolekha & Taksinamanee ( 1980) . In contrast, Lustgarten & Wenk ( 1972) , showed a small negative influence from acetoacetate. In our study we have examined the kinetic and spectrophotometric features of the reactions that occur between alkaline picrate ( 11.3 mwpicric acid/83 mM-NaOH) and (i) creatinine (0.03 1 pmol/ml reaction volume), (ii) acetoacetate (0.125, 0.25 and 1.25 pmol/ml reaction volume) and (iii) acetoacetate/creatinine solutions at the concentrations given in (i) and (ii).
The reference method from Varley (1967) was used to determine the creatinine concentrations. The experiments described were carried out in a Pye-Unicam SP1800 spectrophotometer with a four-position thermostated cell holder (SP874) maintained at 37"C, SP 1805 programme controller, AR-25 linear recorder and 1 cm matched quartz cuvettes. Depending on the experiment, 0.5 ml of 'standard' lithium salt of acetoacetic acid solution was added to 1.5 ml of distilled water or 0.75 ml of 'standard' creatinine solution and 0.75 ml distilled water followed by the addition of a saturated solution of picric acid at 37°C. The reaction was started by the addition of NaOH and the reaction followed at 403 nm. The difference absorption spectra of the reaction mixtures were recorded against alkaline picrate solution as a function of wavelength at the completion of the reaction.
The time course of the simultaneous reaction of 1.25 mwacetoacetate, 0.03 1 mwcreatinine and 1.25 mMacetoacetate/0.03 1 mwcreatinine with alkaline picrate solution are shown in Fig. l(a) . The reaction between acetoacetate and alkaline picrate showed a sharp increase in absorbance in the first minute which gradually decreased over 7 min and was followed by a constant absorbance of 0.13 at 30 min. However, at acetoacetate concentrations of 0.125 mM and 0.25 mM, no similar patterns were discerned because the final absorbance was low in each case (0.025 and 0.05, respectively). The creatinine/alkaline picrate reaction was complete at 13-15 min and gave a final absorbance of 0.43 at 30 min. The acetoacetate/creatinine/alkaline picrate reaction gave a similar pattern of reaction time course, but at any given time the absorbance was 0.07-0.105 greater than t Present address: Clinical Biochemistry Department, Royal Berkshire Hospital, Reading RGI 5AN, U.K. Vol. 16
BIOCHEMICAL SOCIETY TRANSACTIONS for the alkaline creatinine picrate complex. The final absorbance was 0.50. The difference in absorbance between the acetoacetate/creatinine reaction time course and the acetoacetate/alkaline picrate time course was not equal to that of the formation of the alkaline creatinine picrate complex. The absorbance changes of the individual reactions were not additive. The final absorbance values for the reaction between acetoacetate and creatinine solution at acetoacetate concentrations of 0.125 mM and 0.25 mM were in good agreement with the final absorbance of the alkaline creatinine picrate complex.
The difference absorption spectra of the reaction mixtures as presented in Fig. 1( 6) show that the maximum absorbance of 1.25 mwacetoacetate in alkaline picrate occurs in the region of 482-484 nm. The maximum absorbance of the product of reaction between acetoacetate/creatinine solution and alkaline picrate solution occurs at 485 nm compared with 493 nm for the alkaline creatinine picrate complex. Hence, there is a shift in the peak absorbance due to the presence of acetoacetate in the reaction.
Our results show that at 1.25 mM-final acetoacetate concentration (equivalent to plasma acetoacetate concentration of 10 mmol/l), there is an increase in the final absorbance which is due to the presence of acetoacetate. Therefore at high concentrations, acetoacetate interferes in the determination of creatinine by the Jaffe reaction.
At final acetoacetate concentrations of 0.125 mM and 0.25 mM (equivalent to 1 and 2 mmol/l plasma acetoacetate concentration) there is no interference in the determination of creatinine within the limits of experimental error. The evidence for interference by bilirubin in the determination of creatinine by the Jaffe method is ambiguous. It has been reported by Watkins et al. (1976) , Soldin et al. (1977) and Osberg & Hammond (1978) that in the reaction, unconjugated bilirubin underwent oxidation to biliverdin in the presence of alkali, which resulted in a decrease in absorbance at 510 nm and an increase in absorbance at 630 nm. The changes in absorbance were said to contribute to a negative blank. This interpretation has been questioned by Knapp & Hadid (1987) , who have surmised that the hydroxide reagent used in the Beckman method for creatinine contained a substance which inhibited the oxidation of bilirubin and therefore prevented the changes in absorbance at 5 10 nm and 630 nm. We have performed experiments to study the behaviour of bilirubin in varying concentrations of alkali (3 mM-, 72.3 mMand 83 mM-NaOH, final assay concentration), before carrying out an investigation into the behaviour of bilirubin in alkaline picrate solution.
Bilirubin ( 5 13 p~) was prepared by dissolving 3.0 mg of unconjugated bilirubin (Sigma Chemical Co. Ltd, product no. B 4126) in 0.3 ml of 0.1 M-NaOH and adjusting the volume to 10 ml with distilled water (Cardenas-Vazquez el al., 1986). The stock solution was diluted (1:4, by vol) in 0.003 M-NaOH and a further dilution (1 :6, by vol) in the assay mixture gave the final assay concentration of 21 p~-bilirubin. Solutions of bilirubin were used immediately after preparation and protected from light in aluminium foil.
The experiments were carried out in a Pye-Unicam SP 1800 spectrophotometer with a four-position thermostated cell holder (SP874) maintained at 37"C, SP1805 programme controller, AR-25 linear recorder and 1 cm 1-Present address: Clinical Biochemistry Department, Royal Berkshire Hospital, Reading RGl 5AN, U.K. matched quartz cuvettes. An aliquot (0.5 ml) of 128 p~-bilirubin solution was added to 2.5 ml of NaOH ( 3 mM, 72.3 mM or 83 mM, final assay concentration). The absorbance of the solutions of bilirubin in NaOH were recorded as a function of wavelength at different time intervals against the appropriate NaOH blank solution. Solutions of bilirubin were left exposed to light at 493 nm in the spectrophotometer between recordings.
The absorption spectrum of a solution of bilirubin (0.021 mM final assay concentration) in 3 mM-NaOH is shown in Fig. 1( a) . The maximum absorbance was observed at 440 nm and was noted to be 1.08 at t = 1.5 min after addition of bilirubin solution to the cuvette and 0.91 at t = 130 min. The molar absorption coefficient was calculated to be 5 1 430 at 440 nm (cf. 60000 at 453 nm in CHCI,). The apparent rate of decrease of absorbance of bilirubin in 0.003 M-NaOH at 440 nm was A0.0013/min ( A t = 128.5 min).
The difference absorption spectrum of a solution of bilirubin (0.021 pmol/ml reaction mixture volume) in 8 3 mMNaOH is shown in Fig. l(6) . The maximum absorbance of 0.91 occurred at 430 nm (spectrum 1) and decreased with time to 0.28 (spectrum 8). The rate of loss of absorbance of bilirubin at 430 nm was A0.0056/min. At 120 min, a peak had formed with maximum absorbance at 310 nm and an isosbestic point was observed at 350-352 nm.
The behaviour of 21 pM-bilirubin in 72.3 mM-NaOH was studied by recording the absorbance of the solution at various time intervals at wavelengths from 410 nm to 700 nm. The maximum absorbance of the solution was found at 430 nm at the beginning of the experiment and at 420 nm after 120 min. The rate of decrease in absorbance at 430 nm was A0.004 1 /min.
There was no evidence in our experiments of an increase in absorbance at 630 nm which might have been due to the oxidation of bilirubin to biliverdin in an alkaline medium (Fig. 16) . The apparent rate of decrease in absorbance of 0.021 mM-bilirubin in NaOH solution when exposed to light at 493 nm was greater in 83 mM-NaOH (A0.0056/min) than in 72.3 mM-NaOH (A0.0041/min) or in 3 mM-NaOH (AO.O013/min). The results imply that the rate of decay of bilirubin in NaOH solutions increases with increase in the concentration of alkali.
